Auron Therapeutics
0 followers
‌
Auron Therapeutics aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to the transformation of malignant cells into more normal functioning cells.
Industries
Headquarters
Employees
Links
Org chart
Kate Yen
Founder & CEO
Kate Yen
Collapse
Christopher D. T. Guiffre
President & COO
Andrea Armstrong
Chief People Officer
David Millan
Chief Scientific Officer
Colleen Desimone
SVP, Finance
Mark Bittinger
VP, Translational Biology
Laura Antipov
Senior Director, Head of R&D Strategy & Operations
Betty Chan
Director, Biochemistry & Biophysics
Joe DeBartolo
Director, Computational Biology
James Neef
Director, Chemistry
Thomas Graeber
Chief Data Officer
Chris Guiffre
President & COO
Sara Sinicropi-Yao
Principal Scientist, Translational Biology
